The University of Kentucky and Baptist Health Lexington have been selected to conduct a COVID-19 vaccine trial, according to an announcement from the university on Thursday.
UK and Baptist Health Lexington will also partner with Norton Healthcare for the trial, which will enroll 2,000 local volunteers, according to the announcement.
Below is more information about the trial, from the University of Kentucky.
The purpose of this clinical research study is to determine the efficacy (whether it works) and safety of an investigational vaccine for the prevention of COVID-19.
This investigational vaccine does not contain live COVID-19 virus and cannot cause you to contract COVID-19.
You may be able to participate in this study if you are at least 18 years old. Additional eligibility criteria will be assessed by the study doctor or staff during the screening process prior to being enrolled in the study and receiving any investigational vaccine. Not all individuals may qualify to participate in the research.
While we encourage everyone to get a flu shot, please note that study participants cannot have a flu shot within two weeks before or after receiving the study injection.
For more information, visit stopcovidky.com
